Ironwood Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 4.49
| IRWD Stock | USD 1.51 0.03 1.95% |
Ironwood |
Ironwood Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ironwood Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ironwood Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ironwood Pharmaceuticals generated a negative expected return over the last 90 days | |
| Ironwood Pharmaceuticals has high historical volatility and very poor performance | |
| Ironwood Pharmaceuticals may become a speculative penny stock | |
| Ironwood Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 351.41 M. Net Loss for the year was (1 B) with profit before overhead, payroll, taxes, and interest of 241.46 M. | |
| Over 98.0% of the company shares are owned by institutional investors |
Ironwood Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ironwood Stock often depends not only on the future outlook of the current and potential Ironwood Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ironwood Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 160.2 M |
Ironwood Pharmaceuticals Technical Analysis
Ironwood Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Ironwood Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ironwood Pharmaceuticals. In general, you should focus on analyzing Ironwood Stock price patterns and their correlations with different microeconomic environments and drivers.
Ironwood Pharmaceuticals Predictive Forecast Models
Ironwood Pharmaceuticals' time-series forecasting models is one of many Ironwood Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ironwood Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ironwood Pharmaceuticals
Checking the ongoing alerts about Ironwood Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ironwood Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ironwood Pharmaceuticals generated a negative expected return over the last 90 days | |
| Ironwood Pharmaceuticals has high historical volatility and very poor performance | |
| Ironwood Pharmaceuticals may become a speculative penny stock | |
| Ironwood Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 351.41 M. Net Loss for the year was (1 B) with profit before overhead, payroll, taxes, and interest of 241.46 M. | |
| Over 98.0% of the company shares are owned by institutional investors |
Check out Ironwood Pharmaceuticals Backtesting, Ironwood Pharmaceuticals Valuation, Ironwood Pharmaceuticals Correlation, Ironwood Pharmaceuticals Hype Analysis, Ironwood Pharmaceuticals Volatility, Ironwood Pharmaceuticals History as well as Ironwood Pharmaceuticals Performance. For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ironwood Pharmaceuticals. If investors know Ironwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ironwood Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ironwood Pharmaceuticals is measured differently than its book value, which is the value of Ironwood that is recorded on the company's balance sheet. Investors also form their own opinion of Ironwood Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ironwood Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ironwood Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ironwood Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ironwood Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.